HeartFlow has launched the next-generation interactive HeartFlow Plaque Analysis platform, which is designed to enhance clinical decision-making in assessing patient risk in suspected coronary artery disease (CAD).
The advanced tool integrates with FFRᴄᴛ to offer a comprehensive view of a patient’s plaque burden, enabling personalised treatment plans.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The new HeartFlow Plaque Analysis platform provides clinicians with a non-invasive solution to quantify and characterise plaque in the coronary arteries.
By analysing CT angiogram (CCTA) scans, the platform creates a detailed 3D model of the arteries, offering insights into the volume and type of plaque present.
The integration of plaque quantification with lesion-specific FFRᴄᴛ values is a key feature of the interactive experience.
It presents a 3D plaque model and comprehensive analysis, covering various plaque types such as calcified, non-calcified, and low attenuation.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe platform allows for displaying cross-sectional, colour-coded images of each plaque type along the vessel.
HeartFlow said the Plaque Analysis is recognised for its high level of accuracy, with a 95% agreement for total plaque volume measures when compared to the gold standard IVUS.
HeartFlow chief medical officer Campbell Rogers said: “Accurately diagnosing a patient’s risk for coronary artery disease is critical for determining the best treatment. Our new interactive plaque experience marks an exciting era in AI-enabled cardiac technology, where we are now the only company that offers a fully integrated view of a patient’s true burden of coronary artery disease.
“The elevated visualisation of Plaque Analysis integrated with our flagship FFRᴄᴛ Analysis, sets HeartFlow apart as a wholistic solution for CT analysis, enabling physicians to enhance personalised treatment decisions.”
